Healthcare provider profile · identity verified

Brent Keen, MD

Family Practice · KINGSTON, PA · NPI 1023404092

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	599	169
Levothyroxine Sodium	Levothyroxine Sodium	486	110
Omeprazole	Omeprazole	389	110
Amlodipine Besylate	Amlodipine Besylate	378	116
Rosuvastatin Calcium	Rosuvastatin Calcium	362	111
Pantoprazole Sodium	Pantoprazole Sodium	351	111
Lisinopril	Lisinopril	319	84
Metoprolol Succinate	Metoprolol Succinate	305	89
Gabapentin	Gabapentin	295	105
Prednisone	Prednisone	285	161
Losartan Potassium	Losartan Potassium	251	78
Furosemide	Furosemide	234	72
Metformin Hcl Er	Metformin Hcl	196	58
Pravastatin Sodium	Pravastatin Sodium	190	53
Eliquis	Apixaban	177	49
Tamsulosin Hcl	Tamsulosin Hcl	173	57
Fluticasone Propionate	Fluticasone Propionate	172	63
Jardiance	Empagliflozin	167	40
Duloxetine Hcl	Duloxetine Hcl	165	39
Allopurinol	Allopurinol	159	37
Ozempic	Semaglutide	155	47
Venlafaxine Hcl Er	Venlafaxine Hcl	144	30
Albuterol Sulfate Hfa	Albuterol Sulfate	142	63
Famotidine	Famotidine	141	43
Trazodone Hcl	Trazodone Hcl	125	44
Ezetimibe	Ezetimibe	120	37
Hydrochlorothiazide	Hydrochlorothiazide	113	36
Simvastatin	Simvastatin	113	33
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	113	28
Tizanidine Hcl	Tizanidine Hcl	112	53
Citalopram Hbr	Citalopram Hydrobromide	111	29
Metoprolol Tartrate	Metoprolol Tartrate	111	27
Carvedilol	Carvedilol	110	32
Metformin Hcl	Metformin Hcl	110	30
Alprazolam	Alprazolam	108	32
Pregabalin	Pregabalin	108	31
Clopidogrel	Clopidogrel Bisulfate	95	30
Sertraline Hcl	Sertraline Hcl	93	30
Warfarin Sodium	Warfarin Sodium	93	23
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	85	74
Buspirone Hcl	Buspirone Hcl	84	35
Azithromycin	Azithromycin	81	59
Torsemide	Torsemide	80	21
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	78	60
Potassium Chloride	Potassium Chloride	72	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	68	21
Atenolol	Atenolol	67	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	67	17
Tradjenta	Linagliptin	67	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	66	19
Bupropion Xl	Bupropion Hcl	66	26
Irbesartan	Irbesartan	65	20
Finasteride	Finasteride	58	18
Alendronate Sodium	Alendronate Sodium	57	18
Tramadol Hcl	Tramadol Hcl	57	14
Methylprednisolone	Methylprednisolone	55	51
Montelukast Sodium	Montelukast Sodium	54	13
Cephalexin	Cephalexin	51	38
Meloxicam	Meloxicam	51	25
Mounjaro	Tirzepatide	51	suppressed
Azelastine Hcl	Azelastine Hcl	50	21
Ondansetron Odt	Ondansetron	50	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	48	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	48	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	46	13
Labetalol Hcl	Labetalol Hcl	44	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	44	11
Clonazepam	Clonazepam	42	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	42	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	41	41
Triamcinolone Acetonide	Triamcinolone Acetonide	39	31
Cefdinir	Cefdinir	38	26
Breo Ellipta	Fluticasone/Vilanterol	37	12
Doxycycline Hyclate	Doxycycline Hyclate	37	29
Unifine Pentips	Pen Needle, Diabetic	35	11
Valsartan	Valsartan	33	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Ramelteon	Ramelteon	32	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Clobetasol Propionate	Clobetasol Propionate	30	23
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	29	29
Xarelto	Rivaroxaban	28	suppressed
Felodipine Er	Felodipine	27	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	26	20
Trulicity	Dulaglutide	25	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	24	24
Mirtazapine	Mirtazapine	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Levofloxacin	Levofloxacin	22	13
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Temazepam	Temazepam	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Ketoconazole	Ketoconazole	21	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Primidone	Primidone	20	suppressed
Sotalol	Sotalol Hcl	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Ramipril	Ramipril	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Flecainide Acetate	Flecainide Acetate	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Nitroglycerin	Nitroglycerin	17	14
Nystatin	Nystatin	17	15
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Glimepiride	Glimepiride	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Topiramate	Topiramate	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Diazepam	Diazepam	13	suppressed
Metolazone	Metolazone	13	suppressed
Naproxen	Naproxen	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Dapsone	Dapsone	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Glipizide	Glipizide	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error